Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionano Genomics Inc BNGO

Technology Scientific & Technical Instruments
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

First Extensive Validation Study of Saphyr for Constitutional Genetic Disorders by European Consortium Shows 100% Concordance to Standard Cytogenetics and Describes Resolution of Cases of Long-Standing, Undiagnosed Disease

GlobeNewswire July 8, 2020

The UK NHS, the Medical College of Wisconsin, and the Leading South Korean Yonsei University Hospital are Among Newest Adopters of Bionano Saphyr® for Digital Cytogenetic Applications

GlobeNewswire June 26, 2020

Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire June 18, 2020

Bionano Announces Amendment to Proxy Statement for Annual Meeting of Stockholders

GlobeNewswire June 18, 2020

Bionano Genomics to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on June 18

GlobeNewswire June 12, 2020

Data Presented at European Society of Human Genetics (ESHG) Conference Shows Saphyr System has 100% Concordance with Standard Cytogenetics in Leukemias and Constitutional Aberrations

GlobeNewswire June 11, 2020

Bionano Genomics Announces Issuance of US Patent for Combined Nanochannel-Nanopore Device

GlobeNewswire June 8, 2020

Bionano to Participate in Maxim Group's Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing

GlobeNewswire May 27, 2020

Cancer Genomics Consortium Members Demonstrate 100% Concordance Between Bionano Saphyr and Gold Standard Cytogenetics in Leukemia

GlobeNewswire May 19, 2020

Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020

GlobeNewswire May 14, 2020

Bionano Genomics Adds Healthcare and Genomics Industry Experts with Experience in Commercialization and Reimbursement to Its Board of Directors

GlobeNewswire May 4, 2020

Largest North American Site for FSHD Muscular Dystrophy Testing Adopts Bionano Genomics' Saphyr for Majority of Clinical Tests

GlobeNewswire April 22, 2020

BIONANO GENOMICS ANNOUNCES PRICING OF $18 MILLION UNDERWRITTEN PUBLIC OFFERING

GlobeNewswire April 2, 2020

Bionano Genomics to Support Largest Study to Date on COVID-19 Disease Susceptibility

GlobeNewswire March 31, 2020

Three Top European Sites Adopt Bionano Saphyr® for Cancer, Genetics, and Cytogenetic Applications

GlobeNewswire March 23, 2020

Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility

GlobeNewswire March 10, 2020

Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update

GlobeNewswire March 5, 2020

Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5

GlobeNewswire February 28, 2020

Bionano Genomics Releases Saphyr Updates for Industry-Leading Data Yields that Enable Analysis of Complex Cancer Samples at Unprecedented Depths

GlobeNewswire February 24, 2020

Bionano Genomics Data Drives Scientific Discoveries in Solid Tumors and Leukemias, To Be Presented at the 2020 AGBT Conference

GlobeNewswire February 21, 2020